| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Urology | 15 / 123 | 88th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Advances in Urology
Therapeutic Advances in Urology is Scopus-indexed (Q1, CiteScore 6), WoS SCIE, DOAJ. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 1756-2872Verify ISSN ↗1756-2880Verify ISSN ↗
Publisher: SAGE Publications Inc.
Cost to publish: Checking DOAJ for article charges…
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Therapeutic Advances in Urology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q1, CiteScore 6.
What quartile is Therapeutic Advances in Urology in Scopus?
Therapeutic Advances in Urology is Q1 in Urology (rank 15 of 123), by CiteScore 2025.
What is the impact factor of Therapeutic Advances in Urology?
Therapeutic Advances in Urology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6, which places it in quartile Q1 at the 88th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.111, quartile Q1, with an H-index of 48.
How much does it cost to publish in Therapeutic Advances in Urology?
The publisher lists an article processing charge of about US$2,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Therapeutic Advances in Urology and what is its ISSN?
Therapeutic Advances in Urology is published by SAGE Publications Inc. Its print ISSN is 1756-2872 and its online ISSN is 1756-2880.
Is Therapeutic Advances in Urology in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Therapeutic Advances in Urology open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Therapeutic Advances in Urology? — open metrics via OpenAlex
Therapeutic Advances in Urology has an h-index of 56 and a 2-year mean of 2.98 citations per paper (OpenAlex). Its Scopus CiteScore is 6, quartile Q1. On 2-year citations it ranks #15 of 123 Scopus journals in Urology.
Therapeutic Advances in Urology published 49 papers in 2025; its busiest recent year was 2019 with 68. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Therapeutic Advances in Urology? — latest 97 articles, 2025–2026
In its latest 97 research articles (2025–2026), authors are most often from China (21.5%), United States (17.9%) and Türkiye (8.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Therapeutic Advances in Urology? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.